Halyard Health, Inc. (NYSE:HYH) Files An 8-K Results of Operations and Financial Condition

ME Staff 8-k
-
0

Halyard Health, Inc. (NYSE:HYH) Files An 8-K Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition.

Halyard Health, Inc. (the Company) announced its results of
operations for the three months ended March 31, 2017 in a press
release dated May 2, 2017 that is attached and incorporated herein
by reference as Exhibit 99.1.
The information, including exhibits attached hereto in Item 2.02 of
this Current Report, is being furnished and shall not be deemed
filed for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of
that Section. The information in Item 2.02 of this Current Report
shall not be incorporated by reference into any registration
statement or other document to the Securities Act of 1933, as
amended, except as otherwise expressly stated in such filing.
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Company held its Annual Meeting of Stockholders on April 27,
2017. For more information on the proposals presented at the
meeting, see the Proxy Statement, the relevant portions of which
are incorporated herein by reference.
The stockholders elected each of the three nominees to the Board
of Directors for a three-year term by a majority of the votes
cast:
Director
For
Withheld
Broker
Non-Votes
Robert E. Abernathy
36,631,004
885,689
5,851,932
Ronald W. Dollens
37,214,677
302,016
5,851,932
Heidi K. Kunz
37,179,305
337,388
5,851,932
The stockholders ratified the appointment of Deloitte Touche LLP
as the Company’s Independent Registered Public Accounting Firm
to audit the Company’s 2016 financial statements:
For
43,032,069
Against
135,220
Abstain
201,336
Broker Non-Votes
The stockholders approved the advisory resolution approving
executive compensation:
For
36,336,321
Against
986,954
Abstain
193,418
Broker Non-Votes
5,851,932
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No. 99.1. Press release issued by Halyard Health, Inc. on
May 2, 2017.


About Halyard Health, Inc. (NYSE:HYH)

Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment’s product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD.

Halyard Health, Inc. (NYSE:HYH) Recent Trading Information

Halyard Health, Inc. (NYSE:HYH) closed its last trading session up +0.02 at 39.52 with 456,339 shares trading hands.